| Health / Medical Topics |
Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine
A melanoma peptide vaccine complexed with tetanus toxoid with potential antineoplastic activity. Peptide 946 contains a melanoma-specific epitope recognized by melanoma-specific cytotoxic T lymphocytes (CTL). In addition to the peptide 946 sequence, this vaccine contains tetanus toxin, a protein known to stimulate the induction of CD4+ T lymphocytes; it thereby enhances antigen processing and presentation. Vaccination with the peptide 946-tetanus conjugate melanoma vaccine may produce antibodies as well as elicit a cytotoxic T lymphocyte (CTL) response in tumor cells expressing the 946 epitope, thereby decreasing tumor cell growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A melanoma peptide vaccine with potential antineoplastic activity. Peptide 946 melanoma vaccine contains one of the peptide sequences for a melanoma-specific epitope…
A piece of a protein found only on melanoma (a type of skin cancer) cells. It is being used in vaccines to…
A molecule that contains two or more amino acids (the molecules that join together to form proteins). Peptides that contain many…
A gene that encodes an enzyme that is capable of hydrolyzing the peptide bonds found between amino acids in proteins.
The Peptidase Family-M12B (Reprolysin Family, Adamalysins) consists of evolutionarily-related zinc metalloproteases of structural and functional similarity based on sequence conservation or residue…
Enzymes acting on peptide bonds. EC 3.4.-
